Patents by Inventor Geon Go

Geon Go has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RAZOR ASSEMBLY
    Publication number: 20240083055
    Abstract: A razor assembly is proposed. The razor assembly may include a blade housing configured to receive at least one or more shaving blades in a longitudinal direction. The razor assembly may also include a connector disposed on the rear side of the blade housing and a spin housing coupled to the connector. The razor assembly may further include a fixing housing coupled to the spin housing and configured to render the spin housing to be rotatable about a first rotational axis perpendicular to the longitudinal direction. The razor assembly may further include a first restoring force-providing unit configured to provide a restoring force for restoring the spin housing to a first rest position when the spin housing is rotated about the first rotational axis relative to the fixing housing.
    Type: Application
    Filed: November 8, 2023
    Publication date: March 14, 2024
    Inventors: Woo Gyeong GO, Dong Il KIM, Yong Geon KIM, Kyong Sik LEE
  • COMPOSITION FOR INHIBITING GROWTH OF SARS-COV-2 AND METHOD OF PREPARING THE SAME
    Publication number: 20220119381
    Abstract: Disclosed is a composition for inhibiting the growth of virus. More particularly, the composition for inhibiting the growth of virus includes MDPX-V2021 represented by Formula 1, wherein MDPX-V2021 serves to inhibit a post-translational modification (PTM) stage in cells after SARS-CoV-2 penetrates into the body.
    Type: Application
    Filed: November 30, 2020
    Publication date: April 21, 2022
    Applicants: Medicare Pharmaceuticals Inc., MEDICARE LC.
    Inventors: Do Hyun NA, Kyung Pyo KANG, Jin Hwan JUN, Geon GO, Hyeon Jun NA, Sang Jin KANG, Young Hyun NA, Se Jin YOON, Su Ji NA
  • Composition for inhibiting growth of SARS-CoV-2 and method of preparing the same
    Patent number: 11292789
    Abstract: Disclosed is a composition for inhibiting the growth of virus. More particularly, the composition for inhibiting the growth of virus includes MDPX-V2021 represented by Formula 1, wherein MDPX-V2021 serves to inhibit a post-translational modification (PTM) stage in cells after SARS-CoV-2 penetrates into the body.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: April 5, 2022
    Assignees: Medicare Pharmaceuticals Inc., MEDICARE LC.
    Inventors: Do Hyun Na, Kyung Pyo Kang, Jin Hwan Jun, Geon Go, Hyeon Jun Na, Sang Jin Kang, Young Hyun Na, Se Jin Yoon, Su Ji Na